WORKING GROUP 1
Digitisation in Advanced Therapies
Topics covered: IT infrastructure at various stages of development, centralising data capture and analysis, interfacing with other machines, when is it a good idea to digitise considering barriers to entry, what is the best place to start, Industry 4.0 adoption, centralised approach for sharing data.
Outcome: A report outlining hierarchy of need for digitising manufacturing as clinical programs scale up. The goal is to provide guidance to early to mid-stage biotechs on what they need to prioritise to be able to think about digitisation in later stages.
Who should attend?
- Late stage biotechs with experience going through clinical phases 2 and 3 and with experience in preparing for implementing an MES system, and EBR system, or similar. Ideally, those at the forefront of digitisation
- Vendors helping biotechs on their digitisation journey
- Vendors providing technology in this space
FILL OUT THE FORM BELOW TO APPLY FOR THIS WORKING GROUP